BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 157566)

  • 21. Immunological detection of human cardiac rejection.
    Morris RE; Dong E; Struthers CM; Griepp RB; Stinson EB; Billingham ME; Shumway NE
    Surg Forum; 1974; 25(0):282-4. PubMed ID: 4612777
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of T cell sensitization in renal transplant patients with mixed lymphocyte culture-cell-mediated lympholysis.
    Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ
    Transplant Proc; 1987 Apr; 19(2):2873-5. PubMed ID: 2951917
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 24. [The state of transplantation immunology from an experimental viewpoint].
    von Broen B
    Z Exp Chir; 1975; 8(4):198-214. PubMed ID: 162019
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and treatment of acute cardiac allograft rejection.
    Oyer PE; Stinson EB; Bieber CP; Reitz BA; Raney AA; Baumgartner WA; Shumway NE
    Transplant Proc; 1979 Mar; 11(1):296-303. PubMed ID: 377648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of in vitro tissue-associated (mixed lymphocyte kidney culture) immunity by allograft rejection.
    Miller J; Esquenazi V; Olson L; Roth D; Milgrom M; Fuller L
    Transplant Proc; 1987 Feb; 19(1 Pt 1):263-4. PubMed ID: 2978902
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte activation during allograft rejection.
    Hersh EM; Butler WT; Rossen RD; Morgen RO; Suki W
    Transplant Proc; 1971 Mar; 3(1):457-60. PubMed ID: 4937918
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of T-cell depletion on host responses to organ allografts.
    MacLennan I; Baldwin WM; Tilney NL
    Transplant Proc; 1979 Jun; 11(2):1435. PubMed ID: 382534
    [No Abstract]   [Full Text] [Related]  

  • 29. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in human mixed lymphocyte culture reactivity as an indicator of kidney rejection.
    Hattler BG; Miller J
    Transplant Proc; 1972 Dec; 4(4):655-7. PubMed ID: 4264870
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of mixed leukocyte culture reactivity by sera from hemodialysis patients and transplant recipients as an indicator of isoimmunization.
    Suciu-Foca N; Buda JA; Thiem T; Almojera P; Reemtsma KB
    Lab Invest; 1974 Jul; 31(1):1-5. PubMed ID: 4276465
    [No Abstract]   [Full Text] [Related]  

  • 32. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation.
    McKenzie FN; Tadros N; Stiller C; Keown P; Sinclair N; Kostuk W
    Transplant Proc; 1987 Aug; 19(4):3439-41. PubMed ID: 3303513
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific inhibition of cardiac allograft rejection.
    Jenkins AM; Sanders JH; Woodruff MF
    Br J Surg; 1971 Nov; 58(11):859. PubMed ID: 4942030
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for local helper and suppressor function at the site of allograft rejection.
    Ascher NL; Hoffman R; Chen S; Simmons RL
    Surgery; 1980 Aug; 88(2):274-80. PubMed ID: 6446779
    [No Abstract]   [Full Text] [Related]  

  • 36. Superiority of in vitro nondonor-specific immune monitoring over donor-specific assays in detecting a prerejection state.
    Kirchoff C; McGeorge M; Thomas FT; Mendez-Picon G; Thomas JM; Lower RR; Lee HM
    Surg Forum; 1979; 30():297-9. PubMed ID: 120020
    [No Abstract]   [Full Text] [Related]  

  • 37. Posttransplant changes in specific precursor T-cell reactivity: comparison between liver and kidney allograft recipients.
    Wonigeit K; Bockhorn H; Pichlmayr R
    Transplant Proc; 1979 Jun; 11(2):1250-5. PubMed ID: 382500
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 39. On the relationship between initiator and effector cells in the response to major tansplantation antigens.
    Howard JC
    Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057
    [No Abstract]   [Full Text] [Related]  

  • 40. Proceedings: Nature of cells removed from rejecting rat cardiac allografts;
    Macpherson SG; Tilney NL; Strom TB; Carpenter CB
    Br J Surg; 1975 Feb; 62(2):155. PubMed ID: 1090321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.